<!DOCTYPE html><html><head><title>Help for package survAH</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {survAH}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#survAH-package'><p>Survival Data Analysis using Average Hazard</p></a></li>
<li><a href='#ah2'><p>Two-Sample Comparison of Average Hazard</p></a></li>
<li><a href='#cm214_pfs'><p>Sample Reconstructed Data of CheckMate214 Study</p></a></li>
<li><a href='#print.ah2'><p>print.ah2</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Survival Data Analysis using Average Hazard</td>
</tr>
<tr>
<td>Version:</td>
<td>1.0.0</td>
</tr>
<tr>
<td>Date:</td>
<td>2023-01-16</td>
</tr>
<tr>
<td>Description:</td>
<td>Performs two-sample comparisons based on average hazard with survival weight (AHSW) or general censoring-free incidence rate (CFIR) proposed by Uno and Horiguchi (2023) &lt;<a href="https://doi.org/10.1002%2Fsim.9651">doi:10.1002/sim.9651</a>&gt;.</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-2">GPL-2</a></td>
</tr>
<tr>
<td>Depends:</td>
<td>survival, R (&ge; 2.10)</td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>LazyData:</td>
<td>true</td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>7.2.1</td>
</tr>
<tr>
<td>Suggests:</td>
<td>knitr, rmarkdown</td>
</tr>
<tr>
<td>VignetteBuilder:</td>
<td>knitr</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2023-01-16 22:31:18 UTC; miki</td>
</tr>
<tr>
<td>Author:</td>
<td>Hajime Uno <a href="https://orcid.org/0000-0003-0622-8471"><img alt="ORCID iD"src="https://cloud.R-project.org/web/orcid.svg" style="width:16px; height:16px; margin-left:4px; margin-right:4px; vertical-align:middle" /></a> [aut],
  Miki Horiguchi <a href="https://orcid.org/0000-0002-9800-1954"><img alt="ORCID iD"src="https://cloud.R-project.org/web/orcid.svg" style="width:16px; height:16px; margin-left:4px; margin-right:4px; vertical-align:middle" /></a>
    [aut, cre]</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Miki Horiguchi &lt;horiguchimiki@gmail.com&gt;</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2023-01-17 17:30:02 UTC</td>
</tr>
</table>
<hr>
<h2 id='survAH-package'>Survival Data Analysis using Average Hazard</h2><span id='topic+survAH-package'></span>

<h3>Description</h3>

<p>The survAH package performs two-sample comparisons based on average hazard with survival weight (AHSW) or general censoring-free incidence rate (CFIR) proposed by Uno and Horiguchi (2023) &lt;doi:10.1002/sim.9651&gt;.
</p>


<h3>Author(s)</h3>

<p>Hajime Uno, Miki Horiguchi
</p>


<h3>References</h3>

<p>Uno H and Horiguchi M. Ratio and difference of average hazard with survival weight: new measures to quantify survival benefit of new therapy. Statistics in Medicine. 2023;1-17. &lt;doi:10.1002/sim.9651&gt;
</p>


<h3>See Also</h3>

<p>survival survRM2 surv2sampleComp
</p>

<hr>
<h2 id='ah2'>Two-Sample Comparison of Average Hazard</h2><span id='topic+ah2'></span>

<h3>Description</h3>

<p>The <code>ah2</code> function performs two-sample comparisons using the average hazard (AH) as a summary measure of the survival time distribution.
Two kinds of between-group contrast metrics, the ratio of AH (RAH) and the difference in AH (DAH), are calculated.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>ah2(time, status, arm, tau=NULL, conf.int=0.95)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="ah2_+3A_time">time</code></td>
<td>
<p>The follow-up time for right censored data.</p>
</td></tr>
<tr><td><code id="ah2_+3A_status">status</code></td>
<td>
<p>The event indicator, 1=event, and 0=right censored.</p>
</td></tr>
<tr><td><code id="ah2_+3A_arm">arm</code></td>
<td>
<p>The group indicator for comparison. The elements of this vector take either 1 or 0. Normally, 0=control group, 1=active treatment group.</p>
</td></tr>
<tr><td><code id="ah2_+3A_tau">tau</code></td>
<td>
<p>A scalar value to specify a time point for calculating the average hazard. When <code>tau=NULL</code>, the default value (i.e., the maximum time point where the size of risk set for both groups remains at least 10) is used.</p>
</td></tr>
<tr><td><code id="ah2_+3A_conf.int">conf.int</code></td>
<td>
<p>A confidence coefficient for calculating confidence intervals. The default is <code>conf.int=0.95</code>.</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The function provides the AH for each of the two groups, the absolute difference and the absolute ratio of AH (DAH and RAH) between the two groups, and the corresponding confidence intervals.
It also calculates p-values for the two-sided tests based on the RAH and DAH.
</p>


<h3>Value</h3>

<p>an object of class ah2.
</p>
<table>
<tr><td><code>note</code></td>
<td>
<p>the truncation time point used in the analysis</p>
</td></tr>
<tr><td><code>n.obs</code></td>
<td>
<p>the number of observations (total number, number of events by tau, number of censoring by tau, and size of risk set at tau)</p>
</td></tr>
<tr><td><code>ah</code></td>
<td>
<p>the estimated average hazard by arm</p>
</td></tr>
<tr><td><code>rah</code></td>
<td>
<p>the ratio of average hazards (RAH; treatment over control)</p>
</td></tr>
<tr><td><code>dah</code></td>
<td>
<p>the difference of average hazard (DAH; treatment minus control)</p>
</td></tr>
</table>


<h3>Author(s)</h3>

<p>Hajime Uno, Miki Horiguchi
</p>


<h3>References</h3>

<p>Horiguchi M and Uno H. Ratio and difference of average hazard with survival weight: new measures to quantify survival benefit of new therapy. Statistics in Medicine. 2023;1-17. &lt;doi:10.1002/sim.9651&gt;
</p>


<h3>Examples</h3>

<pre><code class='language-R'>#====================================================================
# cm214_pfs: The sample reconstructed data of the CheckMate214 study.
# The code below reproduces the results reported by
# Uno and Horiguchi (StatMed; 2023) in Table 6.
#====================================================================
D      = cm214_pfs
time   = D$time
status = D$status
arm    = D$arm
tau    = 21

a = ah2(time=time, status=status, arm=arm, tau=tau, conf.int=0.95)
print(a, digits=3)
</code></pre>

<hr>
<h2 id='cm214_pfs'>Sample Reconstructed Data of CheckMate214 Study</h2><span id='topic+cm214_pfs'></span>

<h3>Description</h3>

<p>The progression-free survival data reconstructed from the publication of the CheckMate214 study.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>data(cm214_pfs)
</code></pre>


<h3>Format</h3>

<p>A dataset containing 3 columns:
</p>

<dl>
<dt>time</dt><dd><p>the time-to-event variable (the time unit is month)</p>
</dd>
<dt>status</dt><dd><p>the event indicator (1=event, 0=censor)</p>
</dd>
<dt>arm</dt><dd><p>the treatment indicator (1=treatment, 0=control)</p>
</dd>
</dl>



<h3>Details</h3>

<p>This is a reconstructed patient-level data from the results reported by Motzer et al.(2018) &lt;doi:10.1056/NEJMoa1712126&gt;.
The data consists of 847 patients with previously untreated clear-cell advanced renal-cell carcinoma; 425 for the nivolumab plus ipilimumab group (treatment) and 422 for the sunitinib group (control).
</p>


<h3>Source</h3>

<p>Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma.
New England Journal of Medicine. 2018;378(14):1277â€“1290. &lt;doi:10.1056/NEJMoa1712126&gt;
Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12(1):9. &lt;doi:10.1186/1471-2288-12-9&gt;
</p>

<hr>
<h2 id='print.ah2'>print.ah2</h2><span id='topic+print.ah2'></span>

<h3>Description</h3>

<p>S3 method for class 'ah2'
</p>


<h3>Usage</h3>

<pre><code class='language-R'>## S3 method for class 'ah2'
print(x, digits=3, ...)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="print.ah2_+3A_x">x</code></td>
<td>
<p>Object to be printed.</p>
</td></tr>
<tr><td><code id="print.ah2_+3A_digits">digits</code></td>
<td>
<p>Integer indicating the number of decimal places.</p>
</td></tr>
<tr><td><code id="print.ah2_+3A_...">...</code></td>
<td>
<p>Further arguments ignored in this function.</p>
</td></tr>
</table>


<h3>Value</h3>

<p>returns summary output for class 'ah2'
</p>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
